Impaired ACE2 glycosylation and protease activity in Fabry disease protects from COVID-19.

Caputo, Ilaria; Bertoldi, Giovanni; Driussi, Giulia; Sgarabotto, Luca; Carraro, Gianni; Stefanelli, Lucia Federica; Davis, Paul A; Calò, Lorenzo A

Caputo, Ilaria; Bertoldi, Giovanni; Driussi, Giulia; Sgarabotto, Luca; Carraro, Gianni; Stefanelli, Lucia Federica; Davis, Paul A; Calò, Lorenzo A.

Caputo I; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
Bertoldi G; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
Driussi G; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
Sgarabotto L; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
Carraro G; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
Stefanelli LF; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.
Davis PA; Department of Nutrition, University of California, Davis, California, USA.
Calò LA; Nephrology, Dialysis and Transplantation Unit, Department of Medicine, University of Padova, Padova, Italy.

J Intern Med ; 294(2): 238-240, 2023 08.

Artículo en Inglés | MEDLINE | ID: covidwho-20233789

Asunto(s)

COVID-19; Enfermedad de Fabry; Humanos; Enzima Convertidora de Angiotensina 2/metabolismo; Glicosilación; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Enfermedad de Fabry / COVID-19 Límite: Humanos Idioma: Inglés Revista: J Intern Med Asunto de la revista: Medicina Interna Año: 2023 Tipo del documento: Artículo País de afiliación: Joim.13672

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google